Physician profile
Eric Mellon
NPI 1457640062
$3,470.96
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.74 · 2022: $2,235 · 2023: $134 · 2024: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593 · Grant: $350 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.59 |
| Grant | $350.00 |
| Travel and Lodging | $273.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viewray Technologies INC | $2,235.01 | 2022 | |
| Icotec Medical INC. | $566.84 | 2024 | Icotec Blackarmor Spine System |
| Astrazeneca Pharmaceuticals LP | $350.00 | 2024 | |
| Elekta, INC. | $299.37 | 2023-2024 | Elekta Medical Linear Accelerator |
| Lilly USA, LLC | $19.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mellon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.